[REVISION HISTORY]
US research and legislative discussion on psychedelic PTSD
1 recorded revision of this situation.
What changed
2026-11-12 18:52 UTC → 2026-11-19 16:28 UTC ·
added
removed
US psychedelic research for veteran and legislative discussion on psychedelic PTSD
Veterans are increasingly exploring psychedelic treatments, such as psilocybin, to address PTSD and treatment-resistant depression. Research indicates that psilocybin may offer significant reductions in depressive symptoms, with some studies showing high remission rates among participants. Building on this interest, the U.S. Department of Health and Human Services announced plans to provide up to $4.9 million to prepare for clinical trials evaluating ibogaine for PTSD. Health Secretary Robert F. Kennedy Jr. stated the funding is intended to establish foundations for manufacturing, dosing, and clinical evaluation design. Although ibogaine is currently illegal under federal law and carries risks such as heart rhythm issues, officials plan to utilize data from Beond Inc., a company that has treated thousands of individuals with the compound in Mexico. Veterans Affairs Secretary Doug Collins emphasized that this collaborative effort will prioritize safety and high-quality research. Legislative interest has expanded to the U.S. House Committee on Veterans Affairs, where a subcommittee recently held a hearing regarding the implementation of psychedelic-assisted mental health treatments. Lawmakers raised questions about the Department of Veterans Affairs ability to manage these labor-intensive therapies should the Food and Drug Administration grant approval. Data from the Veterans Health Administration suggests approximately 180,000 veterans may qualify for treatments involving compounds such as MDMA, psilocybin, LSD, DMT, and ibogaine. Meanwhile, in New Jersey, community leaders are holding town halls to address concerns regarding equitable access through Medicaid and Medicare, cultural sensitivity, and the necessity of clear evidence on efficacy and safety.
Versions
- 2026-11-19 16:28 UTC US research and legislative discussion on psychedelic PTSD
- 2026-11-12 18:52 UTC US psychedelic research for veteran PTSD
Select a version to see what changed compared to the one before it.